From analgesics to the sustainability of the National Health System

The bells sound in the Monastery of Pedralbes. A group of nuns from the Order of St Claire make their way to prayer. They continued the practice from the founding of the order in 1327 to 1983 when the last habit was seen at this impressive Catalan Gothic site located in the quiet Barcelona neighborhood of Pedralbes. Right next door, at a small house located at number 23 of Monestir Street, the Gebro Group opened its Spanish subsidiary, Gebro Pharma Laboratories, around Christmas 2002. Sergi Aulinas, José Luís Guerrero, Luís Redondo, Carmen Bori, Vicente Ferrer, José Antonio Poch and María Victoria Domínguez raised the curtain on the new venture with a sensation that ebbed between nerves and hope. This group of seven experienced managers joined the Broscheks in the creation of Gebro Spain, uniting Austrian and Spanish capital.

Pascal Broschek had been in Barcelona for two years as he sought to market Seractil and, of course, being an Austrian in love with the sun, he had started to think of how he could expand his business in our country. The Gebro Group then took its most recent step towards internationalization by creating an enclave in southern Europe.

That same year the first promotion campaign was made to 30 medical visitors and the adventure began! Keeping up the company’s tradition of pain relievers, Gebro Pharma Laboratories’ first products were aimed at halting pain. Other products were directed at the heart and we even commercially promoted a stomach protector.

The subsidiary inherited its entrepreneurial spirit from its Austrian parent and the business began to grow. Currently, it has established itself as one of the leading companies in the Spanish pharmaceutical market, especially within the areas of pain and rheumatology, our main area of ​​knowledge. We are also present in the fields of urology, respiratory health and dermatology, and we have new projects in other specialist areas.

More than fifteen years later we continue to improve the lives of more patients through successful experiences in co-promotion, co-marketing and exclusive distribution agreements. But we don’t settle for just that. We extend lives and also reaffirm our commitment to innovation. We work closely with national research centers and institutes, startups and opinion leaders with the objective of strengthening and promoting the research activity of our country. Our maxim is to try to optimize what already exists, identify possible improvements and translate these improvements into solutions.

“We are committed to forming synergies between teams, to collaboration, and to reinvesting benefits in Spain as part of our contribution to the sustainability of the National Health System.

We also cross borders. As a result of our commitment to R&D, in 2018 we signed the first agreement with an international biotech company, an agreement at the Gebro group level in which the company expanded its portfolio in the strategic area of rheumatology.”

In 2019 we reached another milestone, releasing our own product for rheumatology, one designed at Avenida Tibidabo, across Europe.

Our model is simple: commitment to patients, healthcare professionals, collaborators and partners. Only in this way can results be achieved in an ethical and sustainable way! And we do all this following the values ​​from Austria in terms of the quality of our products, respect for the environment and the maintenance of our own corporate identity.

That little congregation that started on Monestir Street now boasts 165 professionals. The house offered restricted space and so in 2009 we moved to Avenida Tibidabo, 29, a street with its own chapter in history to the pharmaceutical industry. Come closer. We invite you to enter the house of the notary Adrià Margarit.

NO